Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel and S-1 in Diffuse Stage III Gastric Cancer
NCT03977220Phase 1Unknown
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jan 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of paclitaxel in gastric cancer (GC), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Recommended dose for Phase II study at 2 years. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03977220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03977220.